Super Micro posted $19.95 billion in Q1 FY2027 sales, up 298%, and raised full-year guidance to $72-82 billion as AI server ...
Operator: Welcome to the IonQ Third Quarter 2026 Earnings Conference Call. [Operator Instructions] I would now like to turn ...
Outlook Therapeutics is building its U.S. commercial organization around LYTENAVA after securing FDA approval for wet age-related macular degeneration. Recent leadership appointments support the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results